person · Reporting owner

HOLLAND CHRISTOPHER S

Disclosed activity across 3 companies

Tapewire entity: 24143
SEC CIK: 0001271440

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
JABIL INCJBL · Entity 3138	Director	April 07, 2026	April 07, 2026
STERIS plcSTE · Entity 3228	Director	August 10, 2026	August 12, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

JABIL INC

Report date April 07, 2026 · Filed April 07, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	11,150	Reported balance After 2026-04-07 transaction · row 1 1 source row Row 1 · 2026-04-07 · Gift · Disposed 960 · Balance 11,150

STERIS plc

Report date August 10, 2026 · Filed August 12, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Career Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	5,989	Reported balance After 2026-08-10 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-08-10 · Grant · Acquired 1,025 · Balance 5,989 F1: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

Filing footnotes · ownership attribution and instrument terms

F1: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.

F2: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

BARD C R INC /NJ/

Report date December 29, 2017 · Filed January 03, 2018

Section 16 reporting ended · disclosed 2018-01-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	44,904.363	Reported balance After 2017-12-29 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2017-12-29 · Grant · Acquired 17,913 · Balance 44,904.363 F1: This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the "Merger") of Lambda Corp. ("Lambda") with and into C. R. Bard, Inc. ("Bard") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company ("BD") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the "Merger Consideration"). All of the transactions reported in this Form 4 occurred simultaneously upon the closing of the Merger. F2: Includes 17,913 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) ("PLTIP"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units.
Common StockSEC Table I · non-derivative	Direct	51,912.363	Reported balance After 2017-12-29 transaction · row 2 Account or security details depend on footnotes; rows are not merged. 1 source row Row 2 · 2017-12-29 · Grant · Acquired 7,008 · Balance 51,912.363 F3: Includes 7,008 Bard restricted stock units deemed acquired upon satisfaction of performance goals that were considered achieved upon the closing of the Merger.
Common StockSEC Table I · non-derivative	Direct	50,944	Reported balance After 2017-12-29 transaction · row 3 Account or security details depend on footnotes; rows are not merged. 1 source row Row 3 · 2017-12-29 · Disposition to issuer · Disposed 968.363 · Balance 50,944 F4: Includes 968.363 shares of Bard common stock that, upon the closing of the Merger, were cancelled and converted into the right to receive the Merger Consideration.
Common StockSEC Table I · non-derivative	Direct	40,673	Reported balance After 2017-12-29 transaction · row 4 Account or security details depend on footnotes; rows are not merged. 1 source row Row 4 · 2017-12-29 · Disposition to issuer · Disposed 10,271 · Balance 40,673 F5: Includes 10,271 Bard restricted stock units that, upon the closing of the Merger, were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent adjusted BD restricted stock units.
Common StockSEC Table I · non-derivative	Direct	22,760	Reported balance After 2017-12-29 transaction · row 5 Account or security details depend on footnotes; rows are not merged. 1 source row Row 5 · 2017-12-29 · Disposition to issuer · Disposed 17,913 · Balance 22,760 F2: Includes 17,913 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) ("PLTIP"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units.
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2017-12-29 transaction · row 6 Account or security details depend on footnotes; rows are not merged. 1 source row Row 6 · 2017-12-29 · Disposition to issuer · Disposed 22,760 · Balance 0 F6: Includes 22,760 shares of restricted stock units acquired through deferral of compensation under Bard's Management Stock Purchase Program ("MSPP"). In accordance with the Merger Agreement (i) each Bard MSPP Unit that by its terms vested and/or became payable at the closing of the Merger was cancelled and converted into, with respect to each share of Bard common stock underlying such Bard MSPP Unit, the right to receive the Merger Consideration; and (ii) each Bard MSPP Unit that did not, by its terms, become payable at the closing of the Merger was assumed and converted in accordance with the exchange ratio set forth in the Merger Agreement into an equivalent adjusted BD MSPP Unit.
Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $186.43 · Expires 2025-12-09	Direct	0	Reported balance After 2017-12-29 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2017-12-29 · Disposition to issuer · Disposed 17,562 · Balance 0 F7: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock.
Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $168.87 · Expires 2024-12-10	Direct	0	Reported balance After 2017-12-29 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2017-12-29 · Disposition to issuer · Disposed 18,837 · Balance 0 F7: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock.
Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $136.37 · Expires 2023-12-11	Direct	0	Reported balance After 2017-12-29 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2017-12-29 · Disposition to issuer · Disposed 5,944 · Balance 0 F7: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock.
Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $219.56 · Expires 2026-12-14	Direct	0	Reported balance After 2017-12-29 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2017-12-29 · Disposition to issuer · Disposed 15,279 · Balance 0 F7: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the "Merger") of Lambda Corp. ("Lambda") with and into C. R. Bard, Inc. ("Bard") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company ("BD") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the "Merger Consideration"). All of the transactions reported in this Form 4 occurred simultaneously upon the closing of the Merger.

F2: Includes 17,913 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) ("PLTIP"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units.

F3: Includes 7,008 Bard restricted stock units deemed acquired upon satisfaction of performance goals that were considered achieved upon the closing of the Merger.

F4: Includes 968.363 shares of Bard common stock that, upon the closing of the Merger, were cancelled and converted into the right to receive the Merger Consideration.

F5: Includes 10,271 Bard restricted stock units that, upon the closing of the Merger, were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent adjusted BD restricted stock units.

F6: Includes 22,760 shares of restricted stock units acquired through deferral of compensation under Bard's Management Stock Purchase Program ("MSPP"). In accordance with the Merger Agreement (i) each Bard MSPP Unit that by its terms vested and/or became payable at the closing of the Merger was cancelled and converted into, with respect to each share of Bard common stock underlying such Bard MSPP Unit, the right to receive the Merger Consideration; and (ii) each Bard MSPP Unit that did not, by its terms, become payable at the closing of the Merger was assumed and converted in accordance with the exchange ratio set forth in the Merger Agreement into an equivalent adjusted BD MSPP Unit.

F7: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
August 10, 2026 Filed Aug 12, 2026 20:32 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	1,025	$0.00	$0.00	Disclosure SEC source: 0001628280-26-056262 · wk-form4_1786566741.xml · derivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,989 Underlying: Ordinary Shares · 1,025 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
April 07, 2026 Filed Apr 7, 2026 21:48 UTC	JABIL INC JBL · Entity 3138	GiftCommon Stock	960	$0.00	$0.00	Disclosure SEC source: 0001225208-26-004431 · doc4.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,150 Read SEC document
January 22, 2026 Filed Jan 26, 2026 23:08 UTC	JABIL INC JBL · Entity 3138	GrantCommon Stock	900	$0.00	$0.00	Disclosure SEC source: 0001225208-26-000860 · doc4.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,110 F1 · kind: Restricted Stock Units ("RSUs") granted pursuant to Issuer's 2021 Equity Incentive Plan ("Plan"), each representing the right to receive one share of Issuer's Common Stock upon vesting. The RSUs vest on January 22, 2027, subject to the terms of the Plan. Read SEC document
August 08, 2025 Filed Aug 12, 2025 21:26 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	975	$0.00	$0.00	Disclosure SEC source: 0001628280-25-039970 · wk-form4_1755033975.xml · derivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,964 Underlying: Ordinary Shares · 975 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
March 24, 2025 Filed Mar 26, 2025 20:27 UTC	JABIL INC JBL · Entity 3138	GiftCommon Stock	1,690	$0.00	$0.00	Disclosure SEC source: 0001225208-25-003640 · doc4.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,210 Read SEC document
January 31, 2025 Filed Feb 3, 2025 21:50 UTC	JABIL INC JBL · Entity 3138	SaleCommon Stock	3,400	$162.27	$551,728.20	Disclosure SEC source: 0001225208-25-001075 · doc4.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,900 Read SEC document
January 23, 2025 Filed Jan 27, 2025 21:41 UTC	JABIL INC JBL · Entity 3138	GrantCommon Stock	1,300	$0.00	$0.00	Disclosure SEC source: 0001225208-25-000901 · doc4.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,300 F1 · kind: Restricted Stock Units ("RSUs") granted pursuant to Issuer's 2021 Equity Incentive Plan ("Plan"), each representing the right to receive one share of Issuer's Common Stock upon vesting. The RSUs vest on January 23, 2026, subject to the terms of the Plan. Read SEC document
October 25, 2024 Filed Oct 28, 2024 20:44 UTC	JABIL INC JBL · Entity 3138	SaleCommon Stock	3,600	$125.23	$450,813.60	Disclosure SEC source: 0001225208-24-009512 · doc4.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Read SEC document
August 08, 2024 Filed Aug 12, 2024 20:34 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	473	$239.68	$113,368.64	Disclosure SEC source: 0001628280-24-036792 · wk-form4_1723494888.xml · nonDerivative · entry 2 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 582 F1 · shares: 473 shares were withheld from the 988 ordinary shares that were awarded on August 8, 2024These 473 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 988 ordinary shares were awarded to Mr. Holland on August 8, 2024. These shares were valued at the NYSE closing market price on August 8, 2024. Read SEC document
August 08, 2024 Filed Aug 12, 2024 20:34 UTC	STERIS plc STE · Entity 3228	GrantOrdinary Shares	988	$239.68	$236,803.84	Disclosure SEC source: 0001628280-24-036792 · wk-form4_1723494888.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,055 Read SEC document
October 19, 2023 Filed Oct 23, 2023 21:27 UTC	JABIL INC JBL · Entity 3138	GrantCommon Stock	1,600	$0.00	$0.00	Disclosure SEC source: 0001225208-23-009668 · doc4.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,600 F1 · kind: Restricted Stock Units ("RSUs") granted pursuant to Issuer's 2021 Equity Incentive Plan ("Plan"), each representing the right to receive one share of Issuer's Common Stock upon vesting. The RSUs vest on October 19, 2024, subject to the terms of the Plan. Read SEC document
October 02, 2023 Filed Oct 4, 2023 20:17 UTC	JABIL INC JBL · Entity 3138	SaleCommon Stock	16,300	$127.37	$2,076,131.00	Disclosure SEC source: 0001225208-23-009316 · doc4.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,000 F1 · price: The transactions reflected on this line were executed in multiple trades at prices ranging from $126.94 to $127.82, inclusive. The price reported above reflects the weighted average sale price for the shares set forth on this line. The reporting person hereby undertakes to provide upon request by the SEC Staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price. Read SEC document
August 03, 2023 Filed Aug 7, 2023 20:35 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	525	$0.00	$0.00	Disclosure SEC source: 0001209191-23-044822 · doc4.xml · derivative · entry 2 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,989 Underlying: Ordinary Shares · 525 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 03, 2023 Filed Aug 7, 2023 20:35 UTC	STERIS plc STE · Entity 3228	GrantDirector Stock Option (right to buy) · Derivative	1,544	$0.00 Strike: $225.50	$0.00	Disclosure SEC source: 0001209191-23-044822 · doc4.xml · derivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,544 Underlying: Ordinary Shares · 1,544 shares Expires 2033-08-03 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
October 20, 2022 Filed Oct 25, 2022 00:19 UTC	JABIL INC JBL · Entity 3138	GrantCommon Stock	3,600	$0.00	$0.00	Disclosure SEC source: 0001225208-22-011090 · doc4.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,300 F1 · kind: Restricted Stock Units ("RSUs") granted pursuant to Issuer's 2021 Equity Incentive Plan ("Plan"), each representing the right to receive one share of Issuer's Common Stock upon vesting. The RSUs vest on October 20, 2023, subject to the terms of the Plan. Read SEC document
August 03, 2022 Filed Aug 5, 2022 20:43 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	1,147	$0.00	$0.00	Disclosure SEC source: 0001209191-22-044580 · doc4.xml · derivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,464 Underlying: Ordinary Shares · 1,147 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
October 21, 2021 Filed Oct 26, 2021 01:19 UTC	JABIL INC JBL · Entity 3138	GrantCommon Stock	3,400	$0.00	$0.00	Disclosure SEC source: 0001225208-21-013259 · doc4.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,700 F1 · kind: Restricted Stock Units ("RSUs"), granted pursuant to the Jabil Inc. 2021 Equity Incentive Plan, each represent the right to receive one share of Issuer's Common Stock upon vesting. The RSUs vest on October 21, 2022. Read SEC document
August 10, 2021 Filed Aug 12, 2021 20:35 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	1,001	$0.00	$0.00	Disclosure SEC source: 0001209191-21-051115 · doc4.xml · derivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,317 Underlying: Ordinary Shares · 1,001 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
June 02, 2021 Filed Jun 4, 2021 20:37 UTC	STERIS plc STE · Entity 3228	GrantOrdinary Shares	7	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-038261 · doc4.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67 F1 · price: Received in exchange for 22 shares of Cantel Medical Corp. ("Cantel") common stock in connection with the acquisition of Cantel by STERIS plc ("STERIS") pursuant to a series of transactions ("Mergers"). Holders of Cantel common stock received $16.93 in cash and 0.33787 STERIS ordinary shares per Cantel share outstanding immediately prior to the Mergers. Read SEC document
October 15, 2020 Filed Oct 19, 2020 21:50 UTC	JABIL INC JBL · Entity 3138	GrantCommon Stock	5,800	$0.00	$0.00	Disclosure SEC source: 0001225208-20-012573 · doc4.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,300 F1 · kind: Restricted Stock Units ("RSUs"), granted pursuant to Issuer's 2011 Stock Award and Incentive Plan, as amended and restated, each represent the right to receive one share of Issuer's Common Stock upon vesting. The RSUs vest on October 15, 2021. Read SEC document
August 04, 2020 Filed Aug 6, 2020 20:31 UTC	STERIS plc STE · Entity 3228	GrantCareer Restricted Stock Units · Derivative	1,316	$0.00	$0.00	Disclosure SEC source: 0001209191-20-045472 · doc4.xml · derivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,316 Underlying: Ordinary Shares · 1,316 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
October 17, 2019 Filed Oct 21, 2019 22:46 UTC	JABIL INC JBL · Entity 3138	GrantCommon Stock	5,800	$0.00	$0.00	Disclosure SEC source: 0001225208-19-013717 · doc4.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,500 F1 · kind: Restricted Stock Units ("RSUs"), granted pursuant to Issuer's 2011 Stock Award and Incentive Plan, as amended and restated, each represent the right to receive one share of Issuer's Common Stock upon vesting. The RSUs vest on October 17, 2020. Read SEC document
October 18, 2018 Filed Oct 22, 2018 21:24 UTC	JABIL INC JBL · Entity 3138	GrantCommon Stock	8,800	$0.00	$0.00	Disclosure SEC source: 0001225208-18-014786 · doc4.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,700 F1 · kind: Restricted Stock Units ("RSUs"), granted pursuant to Issuer's 2011 Stock Award and Incentive Plan, as amended and restated, each represent the right to receive one share of Issuer's Common Stock upon vesting. The RSUs vest on October 18, 2019. Read SEC document
January 25, 2018 Filed Jan 26, 2018 21:27 UTC	JABIL INC JBL · Entity 3138	GrantCommon Stock	5,900	$0.00	$0.00	Disclosure SEC source: 0001225208-18-001623 · doc4.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,900 F1 · kind: This represents the grant of a restricted stock unit award. Each restricted stock unit represents the right to receive one share of Common Stock at vesting. The restricted stock units will vest on January 25, 2019. Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:18 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Disposition to issuerOption (Right to Buy) · Derivative	15,279	Not disclosed Strike: $219.56	Not disclosed	Disclosure SEC source: 0001225208-18-000500 · doc4.xml · derivative · entry 10 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,279 shares Expires 2026-12-14 F7 · price: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. F7 · derivative.exercise_date: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:18 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Disposition to issuerOption (Right to Buy) · Derivative	5,944	Not disclosed Strike: $136.37	Not disclosed	Disclosure SEC source: 0001225208-18-000500 · doc4.xml · derivative · entry 9 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,944 shares Expires 2023-12-11 F7 · price: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. F7 · derivative.exercise_date: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:18 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Disposition to issuerOption (Right to Buy) · Derivative	18,837	Not disclosed Strike: $168.87	Not disclosed	Disclosure SEC source: 0001225208-18-000500 · doc4.xml · derivative · entry 8 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,837 shares Expires 2024-12-10 F7 · price: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. F7 · derivative.exercise_date: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:18 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Disposition to issuerOption (Right to Buy) · Derivative	17,562	Not disclosed Strike: $186.43	Not disclosed	Disclosure SEC source: 0001225208-18-000500 · doc4.xml · derivative · entry 7 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,562 shares Expires 2025-12-09 F7 · price: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. F7 · derivative.exercise_date: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:18 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Disposition to issuerCommon Stock	22,760	$0.00	$0.00	Disclosure SEC source: 0001225208-18-000500 · doc4.xml · nonDerivative · entry 6 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F6 · price: Includes 22,760 shares of restricted stock units acquired through deferral of compensation under Bard's Management Stock Purchase Program ("MSPP"). In accordance with the Merger Agreement (i) each Bard MSPP Unit that by its terms vested and/or became payable at the closing of the Merger was cancelled and converted into, with respect to each share of Bard common stock underlying such Bard MSPP Unit, the right to receive the Merger Consideration; and (ii) each Bard MSPP Unit that did not, by its terms, become payable at the closing of the Merger was assumed and converted in accordance with the exchange ratio set forth in the Merger Agreement into an equivalent adjusted BD MSPP Unit. Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:18 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Disposition to issuerCommon Stock	17,913	$0.00	$0.00	Disclosure SEC source: 0001225208-18-000500 · doc4.xml · nonDerivative · entry 5 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,760 F2 · price: Includes 17,913 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) ("PLTIP"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units. Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:18 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Disposition to issuerCommon Stock	10,271	$0.00	$0.00	Disclosure SEC source: 0001225208-18-000500 · doc4.xml · nonDerivative · entry 4 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,673 F5 · price: Includes 10,271 Bard restricted stock units that, upon the closing of the Merger, were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent adjusted BD restricted stock units. Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:18 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Disposition to issuerCommon Stock	968.363	$0.00	$0.00	Disclosure SEC source: 0001225208-18-000500 · doc4.xml · nonDerivative · entry 3 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,944 F4 · price: Includes 968.363 shares of Bard common stock that, upon the closing of the Merger, were cancelled and converted into the right to receive the Merger Consideration. Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:18 UTC	BARD C R INC /NJ/ BCR · Entity 170698	GrantCommon Stock	7,008	$0.00	$0.00	Disclosure SEC source: 0001225208-18-000500 · doc4.xml · nonDerivative · entry 2 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,912.363 F3 · price: Includes 7,008 Bard restricted stock units deemed acquired upon satisfaction of performance goals that were considered achieved upon the closing of the Merger. Read SEC document
December 29, 2017 Filed Jan 3, 2018 20:18 UTC	BARD C R INC /NJ/ BCR · Entity 170698	GrantCommon Stock	17,913	$0.00	$0.00	Disclosure SEC source: 0001225208-18-000500 · doc4.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,904.363 F1 · security: This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the "Merger") of Lambda Corp. ("Lambda") with and into C. R. Bard, Inc. ("Bard") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company ("BD") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the "Merger Consideration"). All of the transactions reported in this Form 4 occurred simultaneously upon the closing of the Merger. F2 · price: Includes 17,913 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) ("PLTIP"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units. Read SEC document
November 02, 2017 Filed Nov 6, 2017 18:45 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Exercise / conversionOption (Right to Buy) · Derivative	20,410	$0.00 Strike: $97.69	$0.00	Disclosure SEC source: 0001225208-17-017005 · doc4.xml · derivative · entry 5 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,410 shares Expires 2022-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). F5 · derivative.exercise_date: Options fully vested and are currently exercisable. Read SEC document
November 02, 2017 Filed Nov 6, 2017 18:45 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Exercise / conversionOption (Right to Buy) · Derivative	17,832	$0.00 Strike: $136.37	$0.00	Disclosure SEC source: 0001225208-17-017005 · doc4.xml · derivative · entry 4 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,944 Underlying: Common Stock · 17,832 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). F4 · derivative.exercise_date: Of this option grant 17,832 options fully vested and the remaining options vest on December 11, 2017. Read SEC document
November 02, 2017 Filed Nov 6, 2017 18:45 UTC	BARD C R INC /NJ/ BCR · Entity 170698	SaleCommon Stock	38,242	$334.04	$12,774,277.37	Disclosure SEC source: 0001225208-17-017005 · doc4.xml · nonDerivative · entry 3 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,991.363 F2 · price: Represents the weighted average sales price for price increments ranging from $333.69 to $334.38. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document
November 02, 2017 Filed Nov 6, 2017 18:45 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Exercise / conversionCommon Stock	17,832	$136.37	$2,431,749.84	Disclosure SEC source: 0001225208-17-017005 · doc4.xml · nonDerivative · entry 2 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,233.363 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
November 02, 2017 Filed Nov 6, 2017 18:45 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Exercise / conversionCommon Stock	20,410	$97.69	$1,993,750.85	Disclosure SEC source: 0001225208-17-017005 · doc4.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,401.363 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 68.933 shares acquired under the Company's Employee Stock Purchase Plan from February 7, 2017 to August 7, 2017. Read SEC document
February 14, 2017 Filed Feb 15, 2017 16:58 UTC	BARD C R INC /NJ/ BCR · Entity 170698	SaleCommon Stock	618	$240.53	$148,646.30	Disclosure SEC source: 0001225208-17-003415 · doc4.xml · nonDerivative · entry 2 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,922.43 F2 · kind: Sales are pursuant to a previously disclosed 10b5-1 plan. F3 · price: Represents the weighted average sales price for price increments ranging from $240.36 to $240.73. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document
February 13, 2017 Filed Feb 14, 2017 15:20 UTC	BARD C R INC /NJ/ BCR · Entity 170698	SaleCommon Stock	642	$240.09	$154,135.92	Disclosure SEC source: 0001225208-17-003180 · doc4.xml · nonDerivative · entry 2 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,140.43 F2 · kind: Sales are pursuant to a previously disclosed 10b5-1 plan. F3 · price: Represents the weighted average sales price for price increments ranging from $240.05 to $240.12. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document
February 13, 2017 Filed Feb 15, 2017 16:58 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Tax withholdingCommon Stock	600	$240.47	$144,282.00	Disclosure SEC source: 0001225208-17-003415 · doc4.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,182.43 F1 · kind: Shares withheld to pay taxes upon vesting of restricted stock units granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Read SEC document
February 10, 2017 Filed Feb 14, 2017 15:20 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Tax withholdingCommon Stock	623	$239.93	$149,473.28	Disclosure SEC source: 0001225208-17-003180 · doc4.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,782.43 F1 · kind: Shares withheld to pay taxes upon vesting of restricted stock units granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Read SEC document
February 09, 2017 Filed Feb 10, 2017 18:23 UTC	BARD C R INC /NJ/ BCR · Entity 170698	SaleCommon Stock	7,597	$239.57	$1,819,979.86	Disclosure SEC source: 0001225208-17-002833 · doc4.xml · nonDerivative · entry 6 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,405.43 F6 · kind: Sales are pursuant to a previously disclosed 10b5-1 plan. F7 · price: Represents the weighted average sales price for price increments ranging from $239.47 to $239.83. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document
February 08, 2017 Filed Feb 10, 2017 18:23 UTC	BARD C R INC /NJ/ BCR · Entity 170698	Tax withholdingCommon Stock	6,145	$236.68	$1,454,398.60	Disclosure SEC source: 0001225208-17-002833 · doc4.xml · nonDerivative · entry 5 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,002.43 F5 · kind: Shares withheld to pay taxes upon vesting of performance-based restricted stock units granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Read SEC document
February 08, 2017 Filed Feb 10, 2017 18:23 UTC	BARD C R INC /NJ/ BCR · Entity 170698	GrantCommon Stock	1,021	$164.84	$168,304.70	Disclosure SEC source: 0001225208-17-002833 · doc4.xml · nonDerivative · entry 4 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,147.43 F4 · kind: Restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program. Read SEC document
February 08, 2017 Filed Feb 10, 2017 18:23 UTC	BARD C R INC /NJ/ BCR · Entity 170698	GrantCommon Stock	2,382	$235.49	$560,937.18	Disclosure SEC source: 0001225208-17-002833 · doc4.xml · nonDerivative · entry 3 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,126.43 F4 · kind: Restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program. Read SEC document
February 08, 2017 Filed Feb 10, 2017 18:23 UTC	BARD C R INC /NJ/ BCR · Entity 170698	GrantCommon Stock	3,993	$0.00	$0.00	Disclosure SEC source: 0001225208-17-002833 · doc4.xml · nonDerivative · entry 2 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,744.43 F3 · price: Represents common shares acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated), 50% of which vest immediately and the remaining 50% vest in two equal annual installments on February 8, 2018 and February 8, 2019. Read SEC document
February 08, 2017 Filed Feb 10, 2017 18:23 UTC	BARD C R INC /NJ/ BCR · Entity 170698	GrantCommon Stock	11,746	$0.00	$0.00	Disclosure SEC source: 0001225208-17-002833 · doc4.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,751.43 F1 · price: Represents common shares acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). F2 · balance_after: Includes 40.814 shares acquired under the Company's Employee Stock Purchase Plan from August 2, 2016 to February 6, 2017. Read SEC document
December 14, 2016 Filed Dec 16, 2016 15:35 UTC	BARD C R INC /NJ/ BCR · Entity 170698	GrantOption (Right to Buy) · Derivative	15,279	$0.00 Strike: $219.56	$0.00	Disclosure SEC source: 0001225208-16-043395 · doc4.xml · derivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,279 Underlying: Common Stock · 15,279 shares Expires 2026-12-14 F1 · security: Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). F2 · derivative.exercise_date: Options vest in four equal annual installments beginning on December 14, 2017. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.